Diabetes & Endocrinology Recommendations
To view Article Recommendations, you must have an active subscription.
If your access has expired, you can subscribe at $9.95 per month, the first month of your subscription will be free of charge.
If you think you should be able to access this content, please contact us.
Sign in | Subscribe | Recommend to Library
New to F1000? See this week’s top article below for a free preview of a Recommendation.
HEADS OF FACULTY
LATEST RECOMMENDATION
Ivan Martin and Celeste Scotti, University Hospital Basel, Switzerland. F1000 Rheumatology & Clinical Immunology
TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]
5 Recommendations, most recent by
Eivind Berge, Oslo University Hospital, Norway. F1000 Cardiovascular Disorders
- Clinical Trial
- Clinical Trial: RCT
- Confirmation
- Good for Teaching
Past 7 Days
13
New Recommendations
5,686 total
8
New Articles Recommended
4,115 total
Past 30 Days
-
15Articles Classified As Good for Teaching169 total
-
5Articles Classified As Review / Commentary301 total
-
14Articles Classified As Controversial368 total
-
4Articles Classified As Technical Advance228 total
-
23Articles Classified As Confirmation1,126 total
-
8Articles Classified As Novel Drug Target143 total
-
1Articles Classified As Refutation72 total
-
12Articles Classified As Clinical Trial1,079 total
-
19Articles Classified As Interesting Hypothesis762 total
-
47Articles Classified As New Finding3,302 total
INDIVIDUAL SUBSCRIPTIONS
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.
Subscribe for $9.95/monthINSTITUTIONAL SUBSCRIPTIONS
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
Recommend to your LibrarianIf you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.
Request an Institutional Trialyour institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.

